Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma
Authors: M. Sznol, J. W. Clark, J. W. Smith, R. G. Steis, W. J. Urba, L. V. Rubinstein, L. A. VanderMolen, J. Janik, W. H. Sharfman, R. G. Fenton, S. P. Creekmore, P. Kremers, K. Conlon, J. Hersey, J. Beveridge, D. L. Longo
Journal: JNCI Journal of the National Cancer Institute (1992)

Journal Article Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma Get access Mario Sznol, Mario Sznol * Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment,National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md. ; and Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer TreatmentNCI, Bethesda, Md. *Correspondence to : Mario Sznol, M.D., Executive Plaza North, Rm. 715, National Institutes of Health, Bethesda, MD 20892 Search for other works by this author on: Oxford Academic PubMed Google Scholar Jeffrey W. Clark, Jeffrey W. Clark Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar John W. Smith, II, John W. Smith, II Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Ronald G. Steis, Ronald G. Steis Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Walter J. Urba, Walter J. Urba Program Resources Inc./DynCorp, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Lawrence V. Rubinstein, Lawrence V. Rubinstein Biometric Research Branch, Cancer Therapy EvaJuation Program, Division of Cancer TreatmentNCI, Bethesda Search for other works by this author on: Oxford Academic PubMed Google Scholar Louis A. VanderMolen, Louis A. VanderMolen Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar John Janik, John Janik Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar William H. Sharfman, William H. Sharfman Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Robert G. Fenton, Robert G. Fenton Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more Stephen P. Creekmore, Stephen P. Creekmore Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Peter Kremers, Peter Kremers Frederick Memorial Hospital Search for other works by this author on: Oxford Academic PubMed Google Scholar Kevin Conlon, Kevin Conlon Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Jean Hersey, Jean Hersey Frederick Memorial Hospital Search for other works by this author on: Oxford Academic PubMed Google Scholar Joy Beveridge, Joy Beveridge Program Resources Inc./DynCorp, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Dan L. Longo Dan L. Longo Clinical Research Branch, Biological Response Modifiers Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development Center Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 84, Issue 12, 17 June 1992, Pages 929–937, https://doi.org/10.1093/jnci/84.12.929 Published: 17 June 1992 Article history Revision received: 21 February 1992 Accepted: 03 March 1992 Published: 17 June 1992 Received: 21 November 1992